SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Snap, Inc. is a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap is trending as investor focus shifts to the upcoming AWE showcase, where management is expected to unveil next-generation AR Spectacles and clarify the company's long-term hardware strategy. While some community members remain skeptical due to past performance and intense competition from Meta, others are closely watching for potential AI partnerships and signs that the company can finally translate its massive user base into sustained profitability.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi Technologies is experiencing significant volatility driven by high short interest and speculative retail momentum, with traders closely monitoring its technical breakout above key moving averages while debating the company's long-term competitive advantages. Investors are focused on macroeconomic signals like potential rate shifts and infrastructure branding catalysts, leading to intense community debate between bullish long-term holders and skeptics betting on continued price pressure.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing intense downward pressure and negative investor sentiment as rumors of potential acquisitionsmost recently involving Lionsgatefail to appease shareholders frustrated by lackluster organic growth and a perceived lack of content direction. Despite strong institutional ownership and a massive authorized share buyback program, the community remains deeply divided, with many retail investors expressing skepticism over management's strategy and venting frustrations over recent stock performance.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is trending due to significant volatility following a major acquisition announcement and a wider sector sell-off that has left investors divided on the impact of AI on legacy software. While the community is actively debating the company's valuation, share buybacks, and its strategic stake in Anthropic, sentiment remains split between those viewing the stock as a deeply undervalued enterprise play and those fearing further downward pressure from automated trading programs.

FuboTV, Inc. is a consumer-first live TV streaming company with the mission of delivering premium sports, news and entertainment programming that offers greater choice, flexibility and value. The company was founded by David Gandler, Alberto Horihuela Suarez, and Sung Ho Choi on February 20, 2009 and is headquartered in New York, NY.

fuboTV Inc - Ordinary Shares - Class A

fuboTV Inc

FuboTV is trending as the stock shows increased price volatility and a split community sentiment, with bulls anticipating a short squeeze fueled by low float and Disney's ownership, while bears focus on long-term management criticism and continued sub-dollar valuation concerns. The conversation is largely driven by a mix of speculative trading activity around potential acquisition rumors and ongoing frustrations over past reverse stock splits and executive share selling.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is experiencing significant volatility driven by shifting sentiment regarding Middle Eastern energy supply security and ongoing arbitration proceedings. Despite the downward pressure, the community remains divided between those concerned about macro-driven sell-offs and long-term investors pointing to strong fundamental backlogs and potential upside from elevated global LNG spreads.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is experiencing intense market volatility as investors weigh a wave of pipeline updates against concerns over a potential new hantavirus outbreak. The community remains sharply divided, with some betting on a major breakout driven by oncology and vaccine catalysts, while others warn of institutional distribution and price manipulation.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber is trending due to anticipation surrounding the upcoming Cerebras Systems IPO and the company's strategic position in the AI infrastructure and neocloud sector. Investors are actively discussing the stock's low float, recent financing announcements, and the potential impact of its data center expansion on its long-term revenue growth.

Keel Infrastructure Corp. engages in building artificial intelligence focused data centers and energy assets. It focuses on infrastructure and energy required to support high-performance computing and artificial intelligence workloads. The company was founded on April 1, 2026 and is headquartered in New York, NY.

Keel Infrastructure Corp.

Keel Infrastructure Corp

Keel Infrastructure is trending as investors speculate on potential upcoming tenant announcements and the company's progress in converting power-ready sites for high-performance computing. Community sentiment remains split between bullish participants anticipating a major re-rating following contract execution and bearish concerns regarding current earnings and share dilution.

Magnite, Inc. provides a technology solution to automate the purchase and sale of digital advertising inventory for buyers and sellers. It features applications and services for digital advertising sellers including websites, mobile applications, and other digital media properties. The company was founded by Frank Addante, Duc Chau, Craig Roah, Julie Mattern and Brian D. Baumgart on April 20, 2007 and is headquartered in New York, NY.

Magnite Inc

Magnite is currently trending as investors weigh strong CTV growth and strategic partnerships against broader ad-tech sector volatility ahead of earnings. Community discussion is heavily focused on the company's competitive position against major DSPs, expectations for share buybacks, and the ongoing anticipation of a favorable antitrust ruling regarding Google.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TG Therapeutics (TGTX) Soars 7.5%: Is Further Upside Left in the Stock?

TG Therapeutics (TGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

TGTX Rises on Positive Phase I Data for Subcutaneous Briumvi in MG

TG Therapeutics gains after positive phase I data for subcutaneous Briumvi in myasthenia gravis or MG, while a phase II study in MG gets underway.

TGTX Stock Jumps 5% On Positive Early Data For At-Home BRIUMVI In Muscle Disease

Equity

TGTX’s early-stage study showed the injectable form of BRIUMVI delivered quick and meaningful symptom relief in most myasthenia gravis patients. 


Why Is TG Therapeutics Stock Gaining Tuesday?

TGTX stock rises on positive Phase 1 data for subcutaneous BRIUMVI in myasthenia gravis. See what's next for TG Therapeutics.read more...

Why Is TG Therapeutics (TGTX) Down 5.7% Since Last Earnings Report?

TG Therapeutics (TGTX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

TGTX Stock Up on Positive Phase I Data for Subcutaneous Briumvi

TG Therapeutics jumps 9.5% after phase I data show that subcutaneous Briumvi achieved over 60% bioavailability, sustained drug exposure, and was well tolerated.

TG Therapeutics Stock Surges After Drug Trial Update

Shares of TG Therapeutics Inc (NASDAQ: TGTX) are climbing Wednesday after early-stage clinical trial data for new BRIUMVI MS formulation.read more...

TGTX Stock Applies Brakes On 5-Session Losing Streak – Retail Eyes ‘Multi-Billion’ Sales As At-Home Multiple Sclerosis Treatment Gets Boost

The company announced positive Phase 1 results for a subcutaneous formulation of Briumvi, evaluating it against the currently approved IV formulation.

TGTX's Single-Dose Briumvi Hits Bioequivalence Goal in MS Study

TG Therapeutics announces that Briumvi's late-stage ENHANCE study met its goal, supporting a potential single-infusion regimen for relapsing MS patients.

TGTX Stock Rises 29% in 3 Months: Here's What You Should Know

TG Therapeutics gains on strong Briumvi sales growth, higher 2026 revenue guidance and advancing late-stage studies in RMS.

TG Therapeutics is a fully integrated, commercial stage, biotechnology company focused on the acquisition, development and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI® (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. for BRIUMVI to treat adult patients with RMS who have active disease defined by clinical or imaging features. For more information, visit www.tgtherapeutics.com, and follow us on X (formerly Twitter) @TGTherapeutics and on LinkedIn.

Fiscal Period	Estimated	Reported	Surprise	Result
Q2 '26	$0.36	--	--	N/A
Q1 '26	$0.28	$0.12	-56.44%	MISSED
Q4 '25	$0.35	$0.14	-60.28%	MISSED
Q3 '25	$0.22	$2.43	1010.24%	BEAT
Q2 '25	$0.21	$0.17	-19.49%	MISSED

TGTXTG Therapeutics Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q2 '26

Historical Earnings

Latest TGTX News